Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?
Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R; HepatoCATT Study Group for the Multidisciplinary Management of HCC.
Iezzi R, et al. Among authors: agnes s.
Eur J Radiol. 2019 May;114:32-37. doi: 10.1016/j.ejrad.2019.02.030. Epub 2019 Feb 23.
Eur J Radiol. 2019.
PMID: 31005173